GL1X · GenesisL1 explorer

Research workbench

The crystal structure of human fascin 1 R149A K150A R151A mutant

Analyse The crystal structure of human fascin 1 R149A K150A R151A mutant in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4GP0
Type
protein
Length
960 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Fascin
UniProt
Q16658
Ligands
CL, BR
Pockets
9 · best druggability 0.72

Structure

x-ray diffraction · 2 distinct chains · 6% helix, 48% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AFascinprotein4776% helix, 49% strandQ16658
BFascinprotein4836% helix, 47% strandQ16658

Ligands and binding sites

  • CL · Chloride ion · ion · 29 copies · chains A, B
  • BR · Bromide ion · ion · 7 copies · chains A, B
  • GOL · Glycerol · additive · 10 copies · chains A, B
  • DTT · 2,3-dihydroxy-1,4-dithiobutane · additive · 3 copies · chains A, B
  • EPE · 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15950.720.8052CL
25420.650.7673GOL, CL
33010.520.7443CL, GOL
42120.500.7632GOL
5800.490.8217empty

Interfaces

1 interface between chains.

  • A–B · 727 Ų buried · 3 hydrogen bonds · protein-protein

Compared structures

  • 4GP0 · The crystal structure of human fascin 1 R149A K150A R151A mutant · the same entry in another collection · chain A against A, TM-score 1.00
  • Q16658 · AlphaFold monomer V2.0 prediction for fascin (Q16658) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.